The following article appeared on August 26, 2026 on Bloomberg Law On July 27, Johnson & Johnson agreed to a proposed $5.5 billion resolution of about 76,000 ovarian cancer talc claims across the federal multidistrict litigation and related state cases, conditioned on 95% claimant acceptance. J&J didn’t lose a trial to get there. It won an evidentiary […]